
Sign up to save your podcasts
Or


Explore PROTACs, the new frontier in prostate cancer treatment that destroys cancer-feeding proteins, with one drug currently in Phase 3 clinical trials. Learn why annual PSA tests are crucial for early detection in men aged 40-70 and understand NCCN guidelines for screening older men, considering factors like life expectancy. Gain insights into personalized treatment options and the importance of informed decisions for managing prostate cancer.
By Stone4.9
1010 ratings
Explore PROTACs, the new frontier in prostate cancer treatment that destroys cancer-feeding proteins, with one drug currently in Phase 3 clinical trials. Learn why annual PSA tests are crucial for early detection in men aged 40-70 and understand NCCN guidelines for screening older men, considering factors like life expectancy. Gain insights into personalized treatment options and the importance of informed decisions for managing prostate cancer.

13 Listeners

7,213 Listeners

716 Listeners

1,684 Listeners

8,187 Listeners

1,831 Listeners

5 Listeners

71 Listeners

22 Listeners

20,193 Listeners

1,241 Listeners

185 Listeners

14 Listeners

2 Listeners

3,106 Listeners